479 related articles for article (PubMed ID: 17942938)
1. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.
Zhang Q; Yu YA; Wang E; Chen N; Danner RL; Munson PJ; Marincola FM; Szalay AA
Cancer Res; 2007 Oct; 67(20):10038-46. PubMed ID: 17942938
[TBL] [Abstract][Full Text] [Related]
2. Vaccinia virus GLV-1h237 carrying a Walker A motif mutation of mouse Cdc6 protein enhances human breast tumor therapy in mouse xenografts.
Hofmann E; Grummt F; Szalay AA
Int J Oncol; 2011 Mar; 38(3):871-8. PubMed ID: 21249314
[TBL] [Abstract][Full Text] [Related]
3. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
Chen NG; Yu YA; Zhang Q; Szalay AA
J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
[TBL] [Abstract][Full Text] [Related]
4. Novel oncolytic agent GLV-1h68 is effective against malignant pleural mesothelioma.
Kelly KJ; Woo Y; Brader P; Yu Z; Riedl C; Lin SF; Chen N; Yu YA; Rusch VW; Szalay AA; Fong Y
Hum Gene Ther; 2008 Aug; 19(8):774-82. PubMed ID: 18754710
[TBL] [Abstract][Full Text] [Related]
5. Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus.
Lin SF; Yu Z; Riedl C; Woo Y; Zhang Q; Yu YA; Timiryasova T; Chen N; Shah JP; Szalay AA; Fong Y; Wong RJ
Surgery; 2007 Dec; 142(6):976-83; discussion 976-83. PubMed ID: 18063085
[TBL] [Abstract][Full Text] [Related]
6. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
[TBL] [Abstract][Full Text] [Related]
7. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.
Gentschev I; Stritzker J; Hofmann E; Weibel S; Yu YA; Chen N; Zhang Q; Bullerdiek J; Nolte I; Szalay AA
Cancer Gene Ther; 2009 Apr; 16(4):320-8. PubMed ID: 18949014
[TBL] [Abstract][Full Text] [Related]
8. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
[TBL] [Abstract][Full Text] [Related]
9. Use of GLV-1h68 for Vaccinia Virotherapy and Monitoring.
Frentzen A; Geissinger U; Tsoneva D; Stritzker J
Methods Mol Biol; 2015; 1317():225-37. PubMed ID: 26072410
[TBL] [Abstract][Full Text] [Related]
10. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
McCart JA; Ward JM; Lee J; Hu Y; Alexander HR; Libutti SK; Moss B; Bartlett DL
Cancer Res; 2001 Dec; 61(24):8751-7. PubMed ID: 11751395
[TBL] [Abstract][Full Text] [Related]
11. Preferential replication of systemically delivered oncolytic vaccinia virus in focally irradiated glioma xenografts.
Advani SJ; Buckel L; Chen NG; Scanderbeg DJ; Geissinger U; Zhang Q; Yu YA; Aguilar RJ; Mundt AJ; Szalay AA
Clin Cancer Res; 2012 May; 18(9):2579-90. PubMed ID: 22379115
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells.
Wang H; Chen NG; Minev BR; Szalay AA
J Transl Med; 2012 Aug; 10():167. PubMed ID: 22901246
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic vaccinia therapy of squamous cell carcinoma.
Yu Z; Li S; Brader P; Chen N; Yu YA; Zhang Q; Szalay AA; Fong Y; Wong RJ
Mol Cancer; 2009 Jul; 8():45. PubMed ID: 19580655
[TBL] [Abstract][Full Text] [Related]
15. A mutant type 2 herpes simplex virus deleted for the protein kinase domain of the ICP10 gene is a potent oncolytic virus.
Fu X; Tao L; Cai R; Prigge J; Zhang X
Mol Ther; 2006 May; 13(5):882-90. PubMed ID: 16569513
[TBL] [Abstract][Full Text] [Related]
16. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
17. Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA.
Seubert CM; Stritzker J; Hess M; Donat U; Sturm JB; Chen N; von Hof JM; Krewer B; Tietze LF; Gentschev I; Szalay AA
Cancer Gene Ther; 2011 Jan; 18(1):42-52. PubMed ID: 20829890
[TBL] [Abstract][Full Text] [Related]
18. The highly attenuated oncolytic recombinant vaccinia virus GLV-1h68: comparative genomic features and the contribution of F14.5L inactivation.
Zhang Q; Liang C; Yu YA; Chen N; Dandekar T; Szalay AA
Mol Genet Genomics; 2009 Oct; 282(4):417-35. PubMed ID: 19701652
[TBL] [Abstract][Full Text] [Related]
19. Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma.
Pugalenthi A; Mojica K; Ady JW; Johnsen C; Love D; Chen NG; Aguilar RJ; Szalay AA; Fong Y
Cancer Gene Ther; 2015 Dec; 22(12):591-6. PubMed ID: 26584530
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
Vähä-Koskela MJ; Kallio JP; Jansson LC; Heikkilä JE; Zakhartchenko VA; Kallajoki MA; Kähäri VM; Hinkkanen AE
Cancer Res; 2006 Jul; 66(14):7185-94. PubMed ID: 16849565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]